ArticleFrontiers in cardiovascular medicine2026
Main branches pulmonary artery stenting in congenital heart diseases: a case series.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Branch pulmonary artery (PA) stenosis is a common complication in congenital heart disease (CHD) that can result in unequal pulmonary perfusion, cyanosis, and increased ventricular workload. Although surgical repair remains an option, pulmonary artery stenting has emerged as a less invasive and effective alternative for restoring vessel patency. Methods: This single-center retrospective study included 18 pediatric patients (median age 5.4 years, range 3 months-17 years) who underwent PA stenting for branch stenosis associated with complex CHD. Patient demographics, procedural characteristics, complications, and follow-up outcomes were analyzed. Results: A total of 19 stents were successfully implanted; 10 in the left PA, 7 in the right PA, and one case of bilateral stenting. The mean pre-procedural oxygen saturation improved from 78.1% ± 12.5 to 91.6% ± 7.3 during follow-up. Procedural success was achieved in all cases. Five complications were recorded, including one case of stent dislodgement requiring surgical retrieval and one case of inadequate stent expansion due to over-compliant pulmonary arteries. Three deaths occurred, all attributed to underlying clinical deterioration rather than the procedure itself. No instances of vascular rupture or pericardial tamponade were observed. Most surviving patients demonstrated sustained improvement in oxygenation and progressed to definitive surgical repair or Fontan completion. Conclusions: Pulmonary artery stenting is a safe and effective intervention for managing branch PA stenosis in complex pediatric CHD, providing significant hemodynamic and clinical benefits with an acceptable complication profile. Careful pre-procedural imaging, appropriate stent selection, and meticulous deployment technique are essential to prevent complications such as dislodgement or incomplete expansion, ensuring durable long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.